MYLAN PHARMS INC FDA Approval ANDA 211161

ANDA 211161

MYLAN PHARMS INC

FDA Drug Application

Application #211161

Documents

Letter2020-09-18

Application Sponsors

ANDA 211161MYLAN PHARMS INC

Marketing Status

None (Tentative Approval)001

FDA Submissions

UNKNOWN; ORIG1TA2020-08-05STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

MYLAN PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211161
            [companyName] => MYLAN PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"MACITENTAN","activeIngredients":"MACITENTAN","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/05\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-08-05
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.